# KLEB Inc – FDA Inspection, Mar 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/kleb-inc/e5e971ef-a499-4485-b079-21ef6776ff9d
Source feed: FDA_Inspections

> FDA inspection 1308704 of KLEB Inc, March 17, 2026. 2 citations under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1308704
- Company Name: KLEB Inc
- Inspection Date: 2026-03-17
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Cincinnati District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1216491 - 2023-08-24
- FDA Inspection 1148296 - 2021-07-28
- FDA Inspection 1040736 - 2018-02-07
- FDA Inspection 957586 - 2016-02-10
- FDA Inspection 837858 - 2013-06-18

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/kleb-inc/4a2a949f-8893-4a4c-afd4-87e1adea1607

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22